Predictive risk factors for peritoneal recurrence after pancreatic cancer resection and strategies for its prevention
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Predictive risk factors for peritoneal recurrence after pancreatic cancer resection and strategies for its prevention
Authors
Keywords
Locally advanced pancreatic cancer, Pancreatic cancer, Peritoneal recurrence
Journal
SURGERY TODAY
Volume 47, Issue 12, Pages 1434-1442
Publisher
Springer Nature
Online
2017-04-22
DOI
10.1007/s00595-017-1531-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel preoperative predictor of pancreatic fistula using computed tomography after distal pancreatectomy with staple closure
- (2017) Yasunari Fukuda et al. SURGERY TODAY
- Locally Advanced Pancreatic Cancer
- (2016) Thilo Hackert et al. ANNALS OF SURGERY
- Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer
- (2016) Hideki Ueno et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Preoperative chemoradiotherapy does not compromise the feasibility of adjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma
- (2016) Hideo Tomihara et al. SURGERY TODAY
- Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Experience
- (2015) Ulrich Nitsche et al. ANNALS OF SURGICAL ONCOLOGY
- Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria
- (2015) Hiroshi Katayama et al. SURGERY TODAY
- Increase in Peritoneal Recurrence Induced by Intraoperative Hemorrhage in Gastrectomy
- (2014) Tomohiro Arita et al. ANNALS OF SURGICAL ONCOLOGY
- Phase II study of FOLFIRINOX for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer
- (2014) Takuji Okusaka et al. CANCER SCIENCE
- Impact of Tumor Grade on Pancreatic Cancer Prognosis: Validation of a Novel TNMG Staging System
- (2013) Matthew M. Rochefort et al. ANNALS OF SURGICAL ONCOLOGY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of preoperative therapy on patterns of recurrence in pancreatic cancer
- (2013) Pavlos Papavasiliou et al. HPB
- Screening for Pancreatic Cancer
- (2012) Katherine E. Poruk et al. ANNALS OF SURGERY
- Perineural Invasion and Lymph Node Involvement as Indicators of Surgical Outcome and Pattern of Recurrence in the Setting of Preoperative Gemcitabine-Based Chemoradiation Therapy for Resectable Pancreatic Cancer
- (2011) Hidenori Takahashi et al. ANNALS OF SURGERY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of Tumor Grade on Prognosis in Pancreatic Cancer: Should We Include Grade in AJCC Staging?
- (2010) Nabil Wasif et al. ANNALS OF SURGICAL ONCOLOGY
- Perioperative Blood Transfusions Promote Pancreas Cancer Progression
- (2010) Douglas Benson et al. JOURNAL OF SURGICAL RESEARCH
- Impact of Operative Blood Loss on Survival in Invasive Ductal Adenocarcinoma of the Pancreas
- (2010) Shunji Nagai et al. PANCREAS
- Extensive Intraoperative Peritoneal Lavage as a Standard Prophylactic Strategy for Peritoneal Recurrence in Patients with Gastric Carcinoma
- (2009) Masafumi Kuramoto et al. ANNALS OF SURGERY
- Intraoperative Blood Loss is a Critical Risk Factor for Peritoneal Recurrence After Curative Resection of Advanced Gastric Cancer
- (2009) Takao Kamei et al. WORLD JOURNAL OF SURGERY
- Pancreatoduodenectomy using a no-touch isolation technique
- (2008) Masahiko Hirota et al. AMERICAN JOURNAL OF SURGERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More